Meeting of the Minds: Addressing the Gray Zone of Immunotherapy for Advanced Non-Small Cell Lung Cancer
View the experts discuss the ins and outs of immunotherapy for advanced non-small cell lung cancer (NSCLC) in the real world.
Credit available for this activity expires: 11/30/2024
Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/998874?ecd=bdc_podcast_libsyn_mscpedu
Create your
podcast in
minutes
It is Free